Martina Rosen Team Janssen Oncology

Megan joined Janssen as an Executive Oncology Specialist in 2017.  Though she spends her working days seeking a cure for cancer, her connection is personal too: Three of her eight siblings have received cancer diagnoses. In addition, her colleague at Janssen, Steve Roebuck was diagnosed with Stage 3MM in February 2017.  She dedicates her R2V ride to Steve.

For me, the Road to Victories Ride is personal.
Martina Rosen
I dedicate my R2V ride to my colleague Steve. His positive outlook and his determination that “Multiple myeloma will not define me” are words that I will never forget.
Read More
09/08/2019
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More